-
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Given Consensus Recommendation of "Moderate Buy" by Analysts
ソース: Buzz FX / 18 10 2024 04:22:13 America/Chicago
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Given Consensus Recommendation of "Moderate Buy" by Analysts Written by MarketBeat October 18, 2024 Share Link copied to clipboard. Shares of 4D Molecular Therapeutics, Inc.
Read more...